P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BTIG Downgrades P3 Health Partners Inc (PIII) to Neutral
April 1, 2024 5:35 AM EDTBTIG analyst David Larsen downgraded P3 Health Partners Inc (NASDAQ: PIII) from Buy to Neutral.
The analyst comments "On Thursday, 3/28/24 AMC, PIII reported 4Q:23 results. Revenue of $346.9M +34% y/y exceeded BTIG / consensus estimates of $300M / $303M but adjusted EBITDA of ($44.3M) was well below BTIG / consensus estimates of ($8.4M) / ($4M). Given the higher than expected medical claims costs, increases in reserves, lack of visibility, and fairly tight cash position, we are downgrading PIII to Neutral. We worry that with... More
